Difference between revisions of "Template:Anticholinergics"

From blackwiki
Jump to navigation Jump to search
m (27 revisions imported)
 
(5 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{Navbox
+
#REDIRECT [[Template:Acetylcholine receptor modulators]]
| name  = Anticholinergics
 
| title = [[Anticholinergic]]s
 
| groupstyle = background-color: LightYellow
 
 
 
| group1 = [[Nicotinic antagonist]]s
 
|  list1 = {{Navbox subgroup
 
  | groupstyle = background-color: LightYellow
 
 
 
  | group1 = [[Ganglionic blocker|Ganglionic]]
 
  |  list1 = ''nondepolarizing'' ([[Mecamylamine]], [[Trimetaphan camsilate|Trimetaphan]], [[Hexamethonium]]){{·}} [[Nicotine|Nicotine (high doses)]]<BR>''note: in [[Parasympathetic nervous system|PNS]], ganglionic blocker can have direct '''antinicotinic''' action at [[Preganglionic fibers|preganglionic]] terminal, but simulate indirect '''antimuscarinic''' activities at [[Postganglionic fibers|postganglionic]] terminal
 
 
 
  | group2 = [[Neuromuscular blocker|Neuromuscular]]
 
  | list2  = {{Navbox subgroup
 
  | liststyle = width:auto;
 
  | groupstyle = width:10em;
 
  | groupstyle = background-color: LightYellow
 
 
 
  | group1 = [[Neuromuscular nondepolarizing agent|Non-depolarising]]
 
  | list1  = {{Navbox subgroup
 
  | groupstyle = background-color: LightYellow
 
 
 
| group1 = [[Curare]] alkaloids
 
| list1  = [[Alcuronium chloride|Alcuronium]]{{·}} [[Dimethyltubocurarinium|Dimethyltubocurarine]]{{·}} [[Tubocurarine]]
 
 
 
| group2 = [[Quaternary ammonium muscle relaxants|4° ammonium]]
 
| list2  =
 
 
 
''short duration:'' [[Mivacurium]]
 
 
 
''intermediate:'' [[Atracurium]]/[[Cisatracurium]]{{·}} [[Fazadinium bromide|Fazadinium]]{{·}} [[Rocuronium]] (short onset){{·}} [[Vecuronium]]
 
 
 
''long:'' [[Doxacurium chloride|Doxacurium]]{{·}} [[Metocurine]]{{·}} [[Pancuronium]]{{·}} [[Pipecuronium bromide|Pipecuronium]]
 
 
 
''unsorted:'' [[Gallamine]]{{·}} [[Hexafluronium bromide|Hexafluronium]]
 
 
 
}}
 
 
 
  | group2 = [[Neuromuscular depolarizing agent|Depolarising]]
 
  | list2  = ''[[choline|choline derivatives]]'' ([[Suxamethonium chloride|Suxamethonium]], [[Succinylcholine]]){{·}} [[Decamethonium]]
 
 
 
}}
 
 
 
}}
 
| group2 = [[Muscarinic antagonist]]s
 
|  list2 = ''nonpolar/tertiary/[[Blood-brain barrier|CNS]]:'' [[Atropine]]{{·}} [[Scopolamine]]{{·}} [[Hyoscyamine]]{{·}} ''[[antiparkinson drug]]s'' ([[Benzatropine]], [[Trihexyphenidyl]], [[Biperiden]])
 
 
 
''polar/quarternary/non-CNS:'' [[Glycopyrrolate]]{{·}} [[Ipratropium]]{{·}} [[Muscarinic acetylcholine receptor M1|M1]] ([[Pirenzepine]]){{·}} [[Muscarinic acetylcholine receptor M3|M3]] ([[Tiotropium]], [[Darifenacin]], [[Vedaclidine]])
 
 
 
''unsorted:'' [[Tropicamide]]{{·}} [[Cyclopentolate]]{{·}} [[Dicycloverine]]{{·}} [[Tolterodine]]{{·}} [[Oxybutynin]]{{·}} [[Homatropine]] {{·}} [[Orphenadrine]]{{·}} [[Diphenhydramine]]{{·}} Other ethanolamine class first-generation [[antihistamines]]
 
 
 
| group3 = Indirect
 
|  list3 = ''acetylcholine synthesis inhibitor'' ([[Hemicholinium-3]]){{·}} ''vesicle storage inhibitor'' ([[Vesamicol]]){{·}} ''acetylcholine release inhibitor'' ([[Botulinum toxin]]){{·}}''acetylcholine release stimulator'' ([[Alpha-latrotoxin]]){{·}} ''acetylcholinesterase reactivators'' ([[Pralidoxime]], [[Obidoxime]])
 
 
 
| group4 =
 
|  list4 =
 
 
 
}}<noinclude>[[Category:Drug templates|{{PAGENAME}}]]</noinclude>
 

Latest revision as of 14:15, 22 October 2020